Markets plunge over possible Chinese regulations

Concerns about potential new trading regulations in China sent the markets tumbling to a sharply lower open with Dow plummeting 258 points to 17,847. Nasdaq plunged 71 points to 4,935.

On the upside

Celanese (NYSE: CE) reported higher first quarter earnings that beat analyst expectations.

Novogen (Nasdaq: NVGN) will collaborate with the Feinstein Institute for Medical Research to develop brain cancer treatments.

Shares of Rosetta Genomics (Nasdaq: ROSG) continued rising.

On the downside

Athersys (Nasdaq: ATHX) reported disappointing results from a Phase 2 study of its MultiStem cell therapy to treat ischemic stroke patients.

Advanced Micro Devices (Nasdaq: AMD) widened first quarter losses more than expected as revenue dropped.

ServiceNow (NYSE: NOW) widened losses for the first quarter and forecast current quarter revenue below analyst estimates.
In the broad market, declining issues outpaced advancers by a margin of more than 4 to 1 on both the NYSE and on Nasdaq. The broader S&P 500 plunged 22 points to 2082. Bitcoin lost $5 to $222.

About this Entry

This page contains a single entry by published on April 17, 2015 6:43 AM.

Modestly lower close over economic data was the previous entry in this blog.

Greece struggles to make payroll, markets plummet is the next entry in this blog.

Find recent content on the main index or look in the archives to find all content.

Powered by Movable Type 5.12